These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 26873405)

  • 1. Understanding the nanoparticle-protein corona complexes using computational and experimental methods.
    Kharazian B; Hadipour NL; Ejtehadi MR
    Int J Biochem Cell Biol; 2016 Jun; 75():162-74. PubMed ID: 26873405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
    Kopac T
    Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
    Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
    Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence correlation spectroscopy as a tool for the study of the intracellular dynamics and biological fate of protein corona.
    Martinez-Moro M; Di Silvio D; Moya SE
    Biophys Chem; 2019 Oct; 253():106218. PubMed ID: 31325709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation coefficients of protein adsorption to nanoparticles as quantitative metrics for description of the protein corona: A comparison of experimental techniques and methodological relevance.
    Hühn J; Fedeli C; Zhang Q; Masood A; Del Pino P; Khashab NM; Papini E; Parak WJ
    Int J Biochem Cell Biol; 2016 Jun; 75():148-61. PubMed ID: 26748245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
    Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
    Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles-cell association predicted by protein corona fingerprints.
    Palchetti S; Digiacomo L; Pozzi D; Peruzzi G; Micarelli E; Mahmoudi M; Caracciolo G
    Nanoscale; 2016 Jul; 8(25):12755-63. PubMed ID: 27279572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein corona primer for physical chemists.
    Payne CK
    J Chem Phys; 2019 Oct; 151(13):130901. PubMed ID: 31594353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
    Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
    ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-related metabolites affect protein-nanoparticle interactions.
    Tavakol M; Montazeri A; Naghdabadi R; Hajipour MJ; Zanganeh S; Caracciolo G; Mahmoudi M
    Nanoscale; 2018 Apr; 10(15):7108-7115. PubMed ID: 29616243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
    Ahsan SM; Rao CM; Ahmad MF
    Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties.
    Liu R; Jiang W; Walkey CD; Chan WC; Cohen Y
    Nanoscale; 2015 Jun; 7(21):9664-75. PubMed ID: 25959034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles.
    Park SJ
    Int J Nanomedicine; 2020; 15():5783-5802. PubMed ID: 32821101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.
    Palchetti S; Pozzi D; Capriotti AL; Barbera G; Chiozzi RZ; Digiacomo L; Peruzzi G; Caracciolo G; Laganà A
    Colloids Surf B Biointerfaces; 2017 May; 153():263-271. PubMed ID: 28273493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
    Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
    Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system.
    Xiao W; Gao H
    Int J Pharm; 2018 Dec; 552(1-2):328-339. PubMed ID: 30308270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.